Last reviewed: November 2017
Last updated: November  2017

Summary

Differentials

Common

  • Minimal change disease
  • Focal segmental glomerulosclerosis (FSGS)
  • Membranous nephropathy
  • Diabetic nephropathy
  • Multiple myeloma-associated AL amyloidosis
  • IgA nephropathy

Uncommon

  • Membranoproliferative (mesangiocapillary) glomerulonephritis
  • Amyloidosis
  • Lupus nephritis
  • Fabry's disease
  • Alport's syndrome
  • Nail-patella syndrome
  • Mercurial nephropathy
  • Malignant hypertension

Contributors

Authors VIEW ALL

Consultant Nephrologist and Professor of Cardio-Renal Medicine

Member of the Faculty of Translational Medicine

King's Health Partners AHSC

London

UK

Disclosures

DJAG has done consultancy work for Sanofi, Otsuka, Relypsa, and Astra-Zeneca.

Core Medical Trainee

London Deanery

Honorary Research Fellow

Institute of Cardiovascular Sciences

University College London

London

UK

Disclosures

OJZ declares that he has no competing interests.

Dr David J.A. Goldsmith and Dr Oliver J. Ziff would like to gratefully acknowledge Dr Michael S. Gersch, a previous contributor to this monograph. MSG declares that he has no competing interests.

Peer reviewers VIEW ALL

Professor of Renal Medicine

The John Walls Renal Unit

Leicester General Hospital

Leicester

UK

Disclosures

JF declares that he has no competing interests.

Associate Director

Nephrology

Washington Hospital Center

Washington

DC

Disclosures

JHV declares that she has no competing interests.

Associate Professor

Department of Medicine

McMaster University

Ontario

Canada

Disclosures

CC declares that she has no competing interests.

Use of this content is subject to our disclaimer